Open AccessGLYCATED HEMOGLOBIN LEVELS IN METABOLIC SYNDROME PATIENTS
Author(s) -
Gautam Mandal,
Sanjay Bhatt
Publication year - 2020
Publication title -
asian journal of pharmaceutical and clinical research
Language(s) - English
Resource type - Journals
eISSN - 2455-3891
pISSN - 0974-2441
DOI - 10.22159/ajpcr.2020.v13i11.39397
Subject(s) - glycated hemoglobin , medicine , glycemic , metabolic syndrome , national cholesterol education program , diabetes mellitus , abdominal obesity , triglyceride , endocrinology , obesity , hemoglobin , cholesterol , type 2 diabetes
Objectives: Metabolic syndrome (MetS) is a cluster of several metabolic disorders including hyperglycemia, reduced high-density lipoprotein cholesterol, and raised triglyceride level in serum, hypertension, and abdominal obesity. Glycated hemoglobin (HbA1c) is used as one of the diagnostic criteria for diabetes and diagnostic tool for MetS.
Methods: The present study was conducted at Prasad Institute of Medical Sciences. The study includes 150 patients with MetS as a case and 150 healthy volunteers as a control. MetS was diagnosed according to National Cholesterol Education Program’s Adult Treatment Panel III criteria. HbA1c was assayed in various components of MetS.
Results: It was found that HbA1c was significantly higher in MetS patients when compared to control group.
Conclusion: Our study suggests that HbA1c might be used as a diagnostic criterion for MetS. Therefore, proper glycemic control should be maintained by maintaining HbA1c level <6.5% to prevent from diabetes and MetS.